MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Operating Expenses Summary of MIRA Pharmaceuticals, Inc.

  • MIRA Pharmaceuticals, Inc.'s latest annual operating expenses in 2023 was 8.52 Million USD , up 20.97% from previous year.
  • MIRA Pharmaceuticals, Inc.'s latest quarterly operating expenses in 2024 Q2 was 1.73 Million USD , down -2.12% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported a annual operating expenses of 7.04 Million USD in annual operating expenses 2022, up 227.48% from previous year.
  • MIRA Pharmaceuticals, Inc. reported a annual operating expenses of 2.15 Million USD in annual operating expenses 2021, up 3082.31% from previous year.
  • MIRA Pharmaceuticals, Inc. reported a quarterly operating expenses of 1.73 Million USD for 2024 Q2, down -2.12% from previous quarter.
  • MIRA Pharmaceuticals, Inc. reported a quarterly operating expenses of 1.33 Million USD for 2023 Q1, down -0.62% from previous quarter.

Annual Operating Expenses Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Operating Expenses of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 8.52 Million USD 20.97%
2022 7.04 Million USD 227.48%
2021 2.15 Million USD 3082.31%
2020 67.62 Thousand USD 0.0%

Peer Operating Expenses Comparison of MIRA Pharmaceuticals, Inc.

Name Operating Expenses Operating Expenses Difference
Amgen Inc. 11.87 Billion USD 99.928%
AstraZeneca PLC 29.57 Billion USD 99.971%
Biogen Inc. 5.2 Billion USD 99.836%
Gilead Sciences, Inc. 13.01 Billion USD 99.934%
Scilex Holding Company 136.49 Million USD 93.753%
Scilex Holding Company 136.49 Million USD 93.753%